Shukra Pharmaceuticals Ltd
Thu 8/10/2026,15:58:27 | NSE : SHUKRAPHAR
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 69.47
Previous Close
₹ 68.32
Volume
7399313
Mkt Cap ( ₹ Cr)
₹ 2935.75
High
₹ 70.40
Low
₹ 66.23
52 Week High
₹ 75.40
52 Week Low
₹ 40.06
Book Value Per Share
₹ 2.34
Dividend Yield
0.01
Face Value
₹ 1.00
What's Your Call?
Collective community sentiment on Shukra Pharmaceuticals Ltd
Your Vote -
Buy
57.14%
Hold
21.43%
Sell
21.43%
57.14%
14 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
66.78
6111
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
6111
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Shukra Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for Allotment Of Shares Pursuant To Conversion Of Warrants
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Clarification From The Company
-
Shukra Pharma. - Price movement
-
Shukra Pharma. - Clarification sought from Shukra Pharmaceuticals Ltd
-
Shukra Pharma. - Voting Results With Scrutinizer Report
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Voting Results And Scrutinizer's Report
-
Shukra Pharma. - Trading Window
-
Shukra Pharma. - Corrigendum To Postal Ballot Notice
-
Shukra Pharma. - Record Date
-
Shukra Pharma. has declared 1% Final dividend for the financial year March 2026
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Reg. 34 (1) Annual Report.
-
Shukra Pharma. - AGM NOTICE
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Update On Date Of AGM
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Announcement under Regulation 30 (LODR)-Dividend Updates
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for Allottment Of Preference Shares
-
Shukra Pharma. - Copy of Newspaper Publication
-
Shukra Pharma. - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
-
Shukra Pharma. - Shareholders meeting
-
Shukra Pharma. - Outcome of Board Meeting
-
Shukra Pharma. - Board Meeting Outcome for AGM And Change Of Name
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Media Release
-
Shukra Pharma. - Board Meeting Intimation for AGM
-
Shukra Pharma. - Reg 30 NSE Listing Done
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Reg 30 Change Of Name In Object
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - General Updates
-
Shukra Pharma. - Reg 30
-
Shukra Pharma. - Reg 30
-
Shukra Pharma. - Media Release
-
Shukra Pharma. - Quarterly Results June 30, 2026
-
Shukra Pharma. - Board Meeting Outcome for Quartely Results June 30, 2026
-
Shukra Pharma. - Update on board meeting
-
Shukra Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended August 03, 2026
-
Shukra Pharma. - Board Meeting Intimation for Quarterly Results
-
Shukra Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Shukra Pharma. - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of The Company Held On Monday, Ju
Key fundamentals
Evaluate the intrinsic value of Shukra Pharmaceuticals Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Liabilities | 94.852 | 67.0125 | 60.7935 | 30.3783 | 19.7265 |
| Equity | 43.7879 | 43.7879 | 10.947 | 3.9142 | 1.5657 |
| Gross Profit | 28.7237 | 12.7297 | 19.4033 | 5.3633 | 2.8857 |
| Net Profit | 22.048 | 9.5751 | 18.5372 | 4.4065 | 0.7507 |
| Cash From Operating Activities | 3.1486 | 7.9184 | -5.1967 | 3.1695 | 7.7843 |
| NPM(%) | 38.88 | 29.38 | 24.85 | 7.48 | 3.66 |
| Revenue | 56.7061 | 32.5873 | 74.5729 | 58.8337 | 20.486 |
| Expenses | 27.9824 | 19.8576 | 55.1696 | 53.4704 | 17.6003 |
| ROE(%) | 21.4 | 9.29 | 18 | 4.27 | 0.72 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shukra Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 793.90 | -2.32 | 20.08 | 39.08 | -26.19 | 0.63 |
| Lotus Eye Hospital and Institute Ltd | 113.94 | -0.78 | 1627.71 | 142.39 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.99 | -1.36 | 24.97 | 893.27 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 714.75 | -4.47 | 0.00 | 152.57 | -363.14 | 0.00 |
Company Info
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1. 2025-The Company has splits its face value from Rs. 10/- to Rs. 1/-.-Shukra Pharmaceuticals bags Rs 24.06 cr Government-Backed Supply Contract for Afghanistan
Read More
Parent Organisation
Shukra Pharmaceuticals Ltd.
Founded
04/03/1993
Managing Director
Mr.Dakshesh Rameshchandra Shah
NSE Symbol
SHUKRAPHAREQ
FAQ
The current price of Shukra Pharmaceuticals Ltd is ₹ 66.78.
The 52-week high for Shukra Pharmaceuticals Ltd is ₹ 70.40 and the 52-week low is ₹ 66.23.
The market capitalization of Shukra Pharmaceuticals Ltd is currently ₹ 2935.75. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shukra Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shukra Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shukra Pharmaceuticals Ltd shares.
The CEO of Shukra Pharmaceuticals Ltd is Mr.Dakshesh Rameshchandra Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
